{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:35:25Z","timestamp":1760549725174},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,3,15]],"date-time":"2015-03-15T00:00:00Z","timestamp":1426377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00432-015-1954-x","type":"journal-article","created":{"date-parts":[[2015,3,14]],"date-time":"2015-03-14T03:27:07Z","timestamp":1426303627000},"page":"1639-1644","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010\u20132012"],"prefix":"10.1007","volume":"141","author":[{"given":"Georg","family":"Maschmeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Olof","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"K\u00e4mpfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ute","family":"Kreibich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"A\u00dfmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maik","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Grobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,15]]},"reference":[{"key":"1954_CR1","first-page":"241","volume-title":"AJCC cancer staging manual","author":"AJCC","year":"2010","unstructured":"AJCC (2010) Exocrine and endocrine pancreas. In: Edge SB, Byrd, Compton CC et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 241\u2013249","edition":"7"},{"key":"1954_CR2","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1200\/JCO.2005.05.0575","volume":"24","author":"JD Hainsworth","year":"2006","unstructured":"Hainsworth JD, Spigel DR, Litchy S, Greco FA (2006) Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network study. J Clin Oncol 24:3548\u20133554","journal-title":"J Clin Oncol"},{"key":"1954_CR3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/PAS.0b013e3181ce1447","volume":"34","author":"DS Klimstra","year":"2010","unstructured":"Klimstra DS, Modlin IR, Adsay NV, Chetty R, Deshpande V, G\u00f6nen M, Jensen RT, Kidd M, Kulke MH, Lloyd RV, Moran C, Moss SF, Oberg K, O\u2019Toole D, Rindi G, Robert ME, Suster S, Tang LH, Tzen CY, Washington MK, Wiedenmann B, Yao J (2010) Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 34:300\u2013313","journal-title":"Am J Surg Pathol"},{"key":"1954_CR4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000182196","volume":"90","author":"G Kl\u00f6ppel","year":"2009","unstructured":"Kl\u00f6ppel G, Couvelard A, Perren A, Komminoth P, McNicol AM, Nilsson O, Scarpa A, Scoazec JY, Wiedenmann B, Papotti M, Rindi G, Pl\u00f6ckinger U (2009) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90:162\u2013166","journal-title":"Neuroendocrinology"},{"key":"1954_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1040-8428(00)00073-1","volume":"37","author":"E Mitry","year":"2001","unstructured":"Mitry E, Rougier P (2001) The treatment of undifferentiated neuroendocrine tumors. Crit Rev Oncol Hematol 37:47\u201351","journal-title":"Crit Rev Oncol Hematol"},{"key":"1954_CR6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bjc.6690325","volume":"81","author":"E Mitry","year":"1999","unstructured":"Mitry E, Baudin E, Ducreux M, Sabourin JC, Rufi\u00e9 P, Aparicio T, Aparicio T, Lasser P, Elias D, Duvillard P, Schlumberger M, Rougier P (1999) Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 81:1351\u20131355","journal-title":"Br J Cancer"},{"key":"1954_CR7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I","volume":"68","author":"CG Moertel","year":"1991","unstructured":"Moertel CG, Kvols LK, O\u2019Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227\u2013232","journal-title":"Cancer"},{"key":"1954_CR8","unstructured":"National Comprehensive Cancer Network (NCCN) (2014) Clinical practice guidelines in oncology: neuroendocrine tumors (Version 1.2015). www.nccn.org . Last access 20 Dec 2014"},{"issue":"Suppl 1","key":"1954_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10555-011-9292-1","volume":"30","author":"K Oberg","year":"2011","unstructured":"Oberg K, Castellano D (2011) Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev 30(Suppl 1):3\u20137","journal-title":"Cancer Metastasis Rev"},{"key":"1954_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/0284186X.2011.582881","volume":"51","author":"IH Olsen","year":"2012","unstructured":"Olsen IH, Langer SW, Jepsen I, Assens M, Federspil B, Hasselby JP, Hansen CP, Kjaer A, Knigge U (2012a) First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. Acta Oncol 51:97\u2013100","journal-title":"Acta Oncol"},{"key":"1954_CR11","doi-asserted-by":"crossref","first-page":"170496","DOI":"10.1100\/2012\/170496","volume":"2012","author":"IH Olsen","year":"2012","unstructured":"Olsen IH, Sorensen JB, Federspil B, Kjaer A, Hansen CP, Knigge U, Langer SW (2012b) Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas. Sci World J 2012:170496","journal-title":"Sci World J"},{"key":"1954_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000335597","volume":"95","author":"M Pavel","year":"2012","unstructured":"Pavel M, Baudin E, Couvelard A, Krenning E, \u00d6berg K, Steinm\u00fcller T, Anlauf M, Wiedenmann B, Salazar R, Barcelona Consensus Conference participants (2012) ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 95:157\u2013176","journal-title":"Neuroendocrinology"},{"key":"1954_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000242109","volume":"90","author":"U Ploeckinger","year":"2009","unstructured":"Ploeckinger U, Kloeppel G, Wiedenmann B, Lohmann R, representatives of 21 German NET Centers (2009) The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors. Neuroendocrinology 90:349\u2013363","journal-title":"Neuroendocrinology"},{"key":"1954_CR14","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.4081\/rt.2013.e39","volume":"5","author":"R Ramella Munhoz","year":"2013","unstructured":"Ramella Munhoz R, de Mendon\u00e7a Rego JF, de Celis Ferrari AR, Braghiroli MI, Mendon\u00e7a Bariani G, Hoff PM, Perego Costa F, Flesch Pfiffer TE, Riechelmann R (2013) Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas. Rare Tumors 5:e39","journal-title":"Rare Tumors"},{"key":"1954_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrendo.2011.120","volume":"8","author":"G Rindi","year":"2011","unstructured":"Rindi G, Wiedenmann B (2011) Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 8:54\u201364","journal-title":"Nat Rev Endocrinol"},{"key":"1954_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"Rindi G, Kl\u00f6ppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, K\u00f6rner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, European Neuroendocrine Tumor Society (ENETS) (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395\u2013401","journal-title":"Virchows Arch"},{"key":"1954_CR17","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","volume":"451","author":"G Rindi","year":"2007","unstructured":"Rindi G, Kl\u00f6ppel G, Couvelard A, Komminoth P, K\u00f6rner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2007) TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451:757\u2013762","journal-title":"Virchows Arch"},{"key":"1954_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.seminoncol.2012.11.011","volume":"40","author":"J Smith","year":"2013","unstructured":"Smith J, Reidy-Langunes D (2013) The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas. Semin Oncol 40:100\u2013108","journal-title":"Semin Oncol"},{"key":"1954_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/annonc\/mds276","volume":"24","author":"H Sorbye","year":"2013","unstructured":"Sorbye H, Welin S, Langer SW, Vestermark LW, Holt N, Osterlund P, Dueland S, Hofsli E, Guren MG, Ohrling K, Birkemeyer E, Thiis-Evensen E, Biagini M, Gronbaek H, Soveri LM, Olsen IH, Federspiel B, Assmus J, Janson ET, Knigge U (2013) Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol 24:152\u2013160","journal-title":"Ann Oncol"},{"key":"1954_CR100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","volume":"39","author":"JR Strosberg","year":"2010","unstructured":"Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, Kvols LK (2010) The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas 39:799\u2013800","journal-title":"Pancreas"},{"key":"1954_CR20","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1002\/cncr.26124","volume":"117","author":"S Welin","year":"2011","unstructured":"Welin S, Sorbye H, Sebjornsen S, Knappskog S, Busch C, Oberg K (2011) Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy. Cancer 117:4617\u20134622","journal-title":"Cancer"},{"key":"1954_CR21","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB (2008) One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063\u20133072","journal-title":"J Clin Oncol"},{"key":"1954_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2009.24.2669","volume":"28","author":"JC Yao","year":"2010","unstructured":"Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, Hoosen S, St Peter J, Haas T, Lebwohl D, Van Cutsem E, Kulke MH, Hobday TJ, O\u2019Dorisio TM, Shah MH, Cadiot G, Luppi G, Posey JA, Wiedenmann B (2010) Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. J Clin Oncol 28:69\u201376","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1954-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-015-1954-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1954-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:40:53Z","timestamp":1559068853000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-015-1954-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,15]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s00432-015-1954-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,15]]}}}